Atea blue­prints Phase 3 for he­pati­tis C com­bo af­ter mid-stage win

Atea Phar­ma­ceu­ti­cals tout­ed da­ta from a mid-stage tri­al study­ing its he­pati­tis C drug com­bo on Wednes­day, an­nounc­ing that it had hit both safe­ty and ef­fi­ca­cy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER